![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: EVI5 |
Gene summary for EVI5 |
![]() |
Gene information | Species | Human | Gene symbol | EVI5 | Gene ID | 7813 |
Gene name | ecotropic viral integration site 5 | |
Gene Alias | EVI-5 | |
Cytomap | 1p22.1 | |
Gene Type | protein-coding | GO ID | GO:0006810 | UniProtAcc | O60447 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
7813 | EVI5 | CCI_1 | Human | Cervix | CC | 6.51e-04 | 8.29e-01 | 0.528 |
7813 | EVI5 | CCI_2 | Human | Cervix | CC | 4.60e-02 | 5.70e-01 | 0.5249 |
7813 | EVI5 | HTA11_3410_2000001011 | Human | Colorectum | AD | 9.98e-22 | -6.49e-01 | 0.0155 |
7813 | EVI5 | HTA11_3361_2000001011 | Human | Colorectum | AD | 1.97e-02 | -5.03e-01 | -0.1207 |
7813 | EVI5 | HTA11_83_2000001011 | Human | Colorectum | SER | 4.64e-07 | -2.41e-01 | -0.1526 |
7813 | EVI5 | HTA11_696_2000001011 | Human | Colorectum | AD | 2.18e-02 | -2.54e-01 | -0.1464 |
7813 | EVI5 | HTA11_5212_2000001011 | Human | Colorectum | AD | 2.40e-04 | -4.57e-01 | -0.2061 |
7813 | EVI5 | HTA11_5216_2000001011 | Human | Colorectum | SER | 1.45e-02 | -6.02e-01 | -0.1462 |
7813 | EVI5 | HTA11_9341_2000001011 | Human | Colorectum | SER | 9.63e-04 | -6.55e-01 | -0.00410000000000005 |
7813 | EVI5 | HTA11_866_3004761011 | Human | Colorectum | AD | 6.27e-10 | -6.16e-01 | 0.096 |
7813 | EVI5 | HTA11_8622_2000001021 | Human | Colorectum | SER | 1.02e-07 | -7.47e-01 | 0.0528 |
7813 | EVI5 | HTA11_10711_2000001011 | Human | Colorectum | AD | 2.52e-05 | -4.90e-01 | 0.0338 |
7813 | EVI5 | HTA11_7696_3000711011 | Human | Colorectum | AD | 4.84e-08 | -4.78e-01 | 0.0674 |
7813 | EVI5 | HTA11_6818_2000001021 | Human | Colorectum | AD | 3.17e-04 | -4.44e-01 | 0.0588 |
7813 | EVI5 | HTA11_99999970781_79442 | Human | Colorectum | MSS | 4.97e-27 | -5.72e-01 | 0.294 |
7813 | EVI5 | HTA11_99999971662_82457 | Human | Colorectum | MSS | 8.37e-03 | -3.32e-01 | 0.3859 |
7813 | EVI5 | HTA11_99999973899_84307 | Human | Colorectum | MSS | 9.37e-10 | -6.94e-01 | 0.2585 |
7813 | EVI5 | HTA11_99999974143_84620 | Human | Colorectum | MSS | 3.72e-26 | -6.80e-01 | 0.3005 |
7813 | EVI5 | A001-C-207 | Human | Colorectum | FAP | 2.56e-05 | -3.73e-01 | 0.1278 |
7813 | EVI5 | A015-C-203 | Human | Colorectum | FAP | 4.82e-33 | -5.30e-01 | -0.1294 |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00430877 | Cervix | CC | regulation of GTPase activity | 79/2311 | 348/18723 | 4.21e-08 | 2.60e-06 | 79 |
GO:00435476 | Cervix | CC | positive regulation of GTPase activity | 53/2311 | 255/18723 | 8.72e-05 | 1.16e-03 | 53 |
GO:00161977 | Cervix | CC | endosomal transport | 48/2311 | 230/18723 | 1.65e-04 | 1.97e-03 | 48 |
GO:00164827 | Cervix | CC | cytosolic transport | 33/2311 | 168/18723 | 4.43e-03 | 2.70e-02 | 33 |
GO:0016197 | Colorectum | AD | endosomal transport | 90/3918 | 230/18723 | 1.88e-10 | 1.73e-08 | 90 |
GO:0016482 | Colorectum | AD | cytosolic transport | 68/3918 | 168/18723 | 6.00e-09 | 3.72e-07 | 68 |
GO:0043087 | Colorectum | AD | regulation of GTPase activity | 110/3918 | 348/18723 | 1.64e-06 | 5.03e-05 | 110 |
GO:0042147 | Colorectum | AD | retrograde transport, endosome to Golgi | 37/3918 | 91/18723 | 1.46e-05 | 3.14e-04 | 37 |
GO:0043547 | Colorectum | AD | positive regulation of GTPase activity | 75/3918 | 255/18723 | 7.95e-04 | 7.91e-03 | 75 |
GO:00161971 | Colorectum | SER | endosomal transport | 61/2897 | 230/18723 | 1.03e-05 | 3.35e-04 | 61 |
GO:00164821 | Colorectum | SER | cytosolic transport | 46/2897 | 168/18723 | 5.20e-05 | 1.25e-03 | 46 |
GO:00430871 | Colorectum | SER | regulation of GTPase activity | 77/2897 | 348/18723 | 5.90e-04 | 8.07e-03 | 77 |
GO:00161972 | Colorectum | MSS | endosomal transport | 79/3467 | 230/18723 | 7.04e-09 | 4.39e-07 | 79 |
GO:00164822 | Colorectum | MSS | cytosolic transport | 59/3467 | 168/18723 | 2.29e-07 | 9.79e-06 | 59 |
GO:00430872 | Colorectum | MSS | regulation of GTPase activity | 101/3467 | 348/18723 | 1.00e-06 | 3.46e-05 | 101 |
GO:00421471 | Colorectum | MSS | retrograde transport, endosome to Golgi | 33/3467 | 91/18723 | 4.78e-05 | 8.71e-04 | 33 |
GO:00435471 | Colorectum | MSS | positive regulation of GTPase activity | 68/3467 | 255/18723 | 7.97e-04 | 8.38e-03 | 68 |
GO:00430873 | Colorectum | FAP | regulation of GTPase activity | 85/2622 | 348/18723 | 1.20e-07 | 7.68e-06 | 85 |
GO:00164823 | Colorectum | FAP | cytosolic transport | 47/2622 | 168/18723 | 1.58e-06 | 6.72e-05 | 47 |
GO:00435472 | Colorectum | FAP | positive regulation of GTPase activity | 61/2622 | 255/18723 | 1.39e-05 | 3.73e-04 | 61 |
Page: 1 2 3 4 5 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
EVI5 | SNV | Missense_Mutation | novel | c.1647N>G | p.His549Gln | p.H549Q | O60447 | protein_coding | tolerated(0.61) | possibly_damaging(0.651) | TCGA-2Y-A9GX-01 | Liver | liver hepatocellular carcinoma | Male | >=65 | I/II | Unknown | Unknown | PD |
EVI5 | deletion | Frame_Shift_Del | novel | c.1081delC | p.Gln361ArgfsTer2 | p.Q361Rfs*2 | O60447 | protein_coding | TCGA-MI-A75E-01 | Liver | liver hepatocellular carcinoma | Male | <65 | III/IV | Unknown | Unknown | SD | ||
EVI5 | SNV | Missense_Mutation | novel | c.1331A>T | p.Glu444Val | p.E444V | O60447 | protein_coding | deleterious(0) | probably_damaging(0.972) | TCGA-05-4405-01 | Lung | lung adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
EVI5 | SNV | Missense_Mutation | c.2356N>A | p.Gly786Ser | p.G786S | O60447 | protein_coding | tolerated_low_confidence(0.75) | benign(0.005) | TCGA-44-7667-01 | Lung | lung adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
EVI5 | SNV | Missense_Mutation | novel | c.1650N>T | p.Trp550Cys | p.W550C | O60447 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-49-AARO-01 | Lung | lung adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | PD |
EVI5 | SNV | Missense_Mutation | c.1687N>T | p.Asp563Tyr | p.D563Y | O60447 | protein_coding | deleterious(0) | possibly_damaging(0.837) | TCGA-55-1596-01 | Lung | lung adenocarcinoma | Male | <65 | I/II | Chemotherapy | carboplatin | CR | |
EVI5 | SNV | Missense_Mutation | novel | c.1986N>C | p.Arg662Ser | p.R662S | O60447 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-55-8204-01 | Lung | lung adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
EVI5 | SNV | Missense_Mutation | novel | c.1091N>T | p.Gln364Leu | p.Q364L | O60447 | protein_coding | deleterious(0.02) | benign(0.155) | TCGA-55-8301-01 | Lung | lung adenocarcinoma | Male | <65 | I/II | Chemotherapy | carboplatin | PR |
EVI5 | SNV | Missense_Mutation | c.1487N>G | p.Gln496Arg | p.Q496R | O60447 | protein_coding | tolerated(0.24) | possibly_damaging(0.796) | TCGA-64-5779-01 | Lung | lung adenocarcinoma | Male | <65 | III/IV | Chemotherapy | cisplatin | PD | |
EVI5 | SNV | Missense_Mutation | novel | c.264N>T | p.Lys88Asn | p.K88N | O60447 | protein_coding | deleterious(0) | probably_damaging(0.997) | TCGA-78-7155-01 | Lung | lung adenocarcinoma | Male | >=65 | I/II | Chemotherapy | carboplatin | PD |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |